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ABSTRACT 
Introduction: Single nucleotide polymorphisms (SNPs)  have lately been used for prediction of 
metabolic processes that may be related to obesity. The aim of our study was to examine the 
association of SNPs of several genes with obesity and physical activity in 18 healthy volunteers.  
Methods: We used buccal swabs to collect and extract DNA from 18 volunteers. 
Pyrosequencing was used for molecular analysis of 13 polymorphisms in 10 genes (APOA2, 
MTHFR, MCM6, PPARG, FABP2, ADRB2, ADRB3, ACTN3, ACE, FUT2). The volunteers’ 
personal data included body mass index (BMI), dietary practice and information on daily fitness 
and workout routine.  Association between the 13 observed gene polymorphisms and individual 
BMI status (normal or overweight) was analysed. Results of the DNA analysis were used for the 
expert evaluation by nutritionists and physiologists to obtain optimal regulation of nutrition and 
exercise. The volunteers had a dietary and fitness programme for 12 months which they tracked 
by filling in a suitable study form.  
Results: 14 volunteers had a moderate genetic predisposition for abdominal adipose-tissue 
accumulation, while 4 of them had a genotypes not associated with abdominal fat tissue 
accumulation. A statistically significant difference was found  between the value of BMI before 
and after the implementation of personalized training and nutrition plan within the group of 
overweight volunteers (paired sample t=3.382; p=0.006; exact p=0.015). The single-locus F-test 
showed no association between the gene polymorphisms and BMI values. In addition, no 
correlation was detected between the gene polymorphisms and amount of BMI reduction prior 
and after the implementation of the personalized training and nutrition plan within the 
overweighed group of volunteers 
Conclusion: Optimal nutrition and training plan is crucial for the BMI reduction as observed in 
the overweighed volunteers after the 12-month personalized training and individualized nutrition 
plan. However, the analysed polymorphisms were not significantly associated with the obesity in 
this study. 
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INTRODUCTION 
Significant technological advances of single-nucleotide polymorphisms (SNPs) have further 
strengthened research methodologies for genetic analyses used to predict metabolic process that 
might be associated with diet and physical activity (1). Obesity is a major epidemic problem of 
the public health worldwide, characterized as an excess of adipose tissue. The most commonly 
used measurement to determine weight status is body mass index (BMI) (2). The World Health 
Organization (WHO) recommends the following BMI cut points to classify weight status in 
adults aged 20 or older: <18.5 kg/m2 (underweight), 18.5–24.9 kg/m2 (normal weight), 25.0–29.9 
kg/m2 (overweight), 30.0–39.9 kg/m2 (obese), and ≥ 40 kg/m2 (extremely obese) (3). Unhealthy 
diet and physical inactivity have been identified as primary determinants of increased obesity. 
Various studies have identified more than 500 candidate genes associated with body weight, 
motor and functional abilities as well as their role in the development of obesity. Therefore, 
genetic factors might be important in determining an individual’s susceptibility to obesity (4,5). 
A number of studies have reported a correlation between variations of a DNA sequence in 
specific genes and the phenotype of obesity (6,7). Genetic variants that influence an individual’s 
response to diet are actually metabolic pathways of fatty acids and carbohydrates, as well as the 
fat cells formation and the production of energy and heat. Some genetic variants are related to 
physical activity in reducing the amount of adipose tissue after the endurance training. 
The aim of our study was to examine the utility of the existing prediction SNP test possibly 
related to obesity and physical activity in 18 healthy volunteers. 
 
METHODS  
We conducted the research on a total of 18 healthy volunteers (50 % male, 50 % female), aged 
20 to 50. The volunteers were assigned into group with normal BMI (7 volunteers) and group 
with increased BMI (11 volunteers). Height and weight were measured with participants dressed 
in lightweight clothing and without shoes. BMI was calculated with the weight (in kilograms) 
divided by the square of height (in meters). All the subjects gave their written informed consent 
for the use of their biological material and data while the ethical approval for this research was 
obtained from the Ethics Committee of the Institute for Genetic Engineering and Biotechnology, 
University of Sarajevo (Approval No. 296-1/14 dated May 13, 2015). 
DNA was extracted from buccal swabs using Chelex® 100, Bio-Rad, according to the 
manufacturer’s protocol. Using public databases, we selected 13 most common polymorphisms 
(Table 1) which are related to obesity development, cardiovascular diseases and metabolic 
disorders, as well as motor and functional abilities of the locomotor system. DNA fragments in 
chromosome 1 (APOA2 and MTHFR), chromosome 2 (MCM6 LCT-13910 and MCM6 LCT-
22018), chromosome 3 (PPARG), chromosome 4 (FABP2), chromosome 5 (ADRB2 position 1 
and position 2), chromosome 8 (ADRB3), chromosome 11 (ACTN3), chromosome 17 (ACE) 
and chromosome 19 (FUT2) were amplified using the polymerase chain reaction (PCR). A 
validated set of reagents (PyroMark PCR Kit, Qiagen) was used for PCR. Amplicon sequences 
were analyzed using pyrosequencing (PyroMark Q24, Qiagen) which was performed in GENOS 
Company. Amplified ACE fragments were separated using capillary electrophoresis using 3130 
genetic analyzer (Applied Biosystems). The fragment size was determined based on the familiar 
molecular weight standard using GeneMapper® ID-X Software (Applied Biosystems).   
 
Statistical analysis  
The Kolmogorov-Smirnov test was applied to estimate the normality of the. In order to estimate 
the difference between BMI before and after the implementation of personalized training and 
nutrition plan, we used the paired samples t-test. Once the difference in BMI between overweight 
and normal groups was calculated, the independent samples t-test was performed. The observed 
sample size was small, therefore, we applied the exact permutation test (N=10000). Biostatistical 
calculations were performed using the Paleontological Statistics (PAST) software, version 3.14 
(8). A single-locus case-control test (9) based on the exact p-value test was performed for the 
allele genotypic association between the 13 observed gene polymorphisms and individual BMI 
status (normal or overweight). When estimating the relationship between the gene 
polymorphisms and BMI value, a single-locus F-test was used. The same test was applied to 
estimate the relationship between the gene polymorphisms and the amount of BMI reduction 
after the implementation of personalized training and nutrition plan. Both the abovementioned 
analyses were conducted using Powermarker v3.25 (10). The statistical significance of p<0.05 
was considered significant.  
RESULTS 
The volunteers’ personal genotypes (Table 2) were subjected to the expert evaluation. 
Personalized training and nutrition plans were obtained for each volunteer.  
According to the obtained genotypes, only 5 volunteers had a genetic predisposition for obesity 
development, while 13 were at moderate risk for weight increase. The genotypes of 8 volunteers 
indicated a genetic predisposition for weight gain due to a diet rich in fats, while the genotypes 
of 10 volunteers showed moderate risk. Furthermore, 14 volunteers reported a moderate genetic 
predisposition for abdominal adipose-tissue accumulation, while it was not the case for the other 
4 volunteers whose genotype was not associated with abdominal fat tissue accumulation. 
Regarding the training program, the personal genotypes of 8 volunteers showed a genetic 
predisposition for a more efficient physiological response to training based on strength exercises. 
According to the genotypes of 10 volunteers, a physiological response to training should be 
equally efficient regardless of whether the training is based on strength or endurance.  
Prior to the 12-month diet and training program, 7 volunteers were in a BMI category with 
normal weight, 9 were in the overweight category, while the remaining 2 volunteers were in the 
obese BMI category. All 18 volunteers have followed the recommended exercise and diet plans. 
After 12 months, BMI values remained unchanged for 8 volunteers. Furthermore, 10 volunteers 
reduced the BMI value and 4 of them even dropped to a lower BMI category (Figure 1).  
The Kolmogorov-Smirnov test showed that all BMI values within observed groups were in a 
range of normal distribution (p0.05). A statistically significant difference was noticed between 
the values of BMI before and after the implementation of the personalized training and nutrition 
plan within the group of volunteers with overweight BMI values (paired samples t=3.382; 
p=0.006; Exact p=0.015). This result showed visible BMI reduction within the group of the 
overweighed volunteers following the implementation of the personalized training and nutrition 
plan. When having included only the volunteers within the normal BMI range, the result showed 
no difference between BMI values before and after the implementation of the personalized 
training and nutrition plan (paired samples t=2.006; p=0.092; Exact p=0.25). The difference 
between the volunteers with normal and increased BMI values was reported before (independent 
samples t=5.129; p=0.000; Exact p=0.000) as well as after (independent samples t=4.915; 
p=0.000; Exact p=0.000) the implementation of the personalized training and nutrition plan. 
Almost one third of the total number of volunteers reduced BMI from overweighed to normal 
after applying the personalized diet and workout program (Table 3). There was no statistically 
significant allelic and genotype association between the 13 observed polymorphisms and 
individual BMI status (normal or overweight) (Table 4). No difference was found in the allele 
and genotype frequency of the observed gene polymorphisms between the male and female 
volunteers (Table 4). The single-locus F-test showed no association between the gene 
polymorphisms and BMI values. In addition, no correlation was detected between the gene 
polymorphisms and amount of BMI reduction prior and after the implementation of the 
personalized training and nutrition plan within the overweighed group of volunteers (Table 5). 
DISCUSSION 
Obesity is increasing worldwide and recent advances in the genomics technology enable the 
prediction of risks for obesity. Sedentary lifestyle and increased calories intake are prominent 
issues that often cause the obesity development and are associated with many metabolic 
disorders.   
Recommendations for the diet and training plan were made according to the genotyping of 18 
volunteers from the population of Bosnia and Herzegovina. Different studies show the 
association between obesity development and diet (3-7). According to the studies, FABP2, 
PPARG, APOA2, ADBR2, ADRB3 polymorphisms are related to nutrition and ADRB2, 
ADRB3, ACE and ACTN3 polymorphisms are related to exercise.  
The intestinal fatty-acid binding protein encoded by FABP2, is involved in lipid metabolism. 
Polymorphism c.163A>G (p.Thr55Ala) (NCBI: rs1799883) is related with the increased binding 
affinity for the long-chain fatty acid, which can cause an increase in BMI and the triglycerides 
level in blood (11). A genotype AA of the FABP2 gene is associated with a moderate risk of 
increased weight gain. Both polymorphisms were detected in all the volunteers, regardless of the 
BMI category.  
The peroxisome proliferators-activated receptor gamma (PPARG) is a transcription factor that 
plays a key role in the adipocyte gene expression and differentiation of adipocytes. Obesity and 
nutritional factors are crucial in the expression of PPARG in human adipocytes. A lower BMI is 
associated with polymorphisms c.-2-28078C>G (p.Pro12Ala) (NCBI: rs1801282) of this gene 
(12,13). However, CC homozygosity was reported in all the participants except for 2 participants 
that presented no changes in BMI values throughout the study. 
An apolipoprotein gene polymorphism c.-323C>T (NCBI: rs5082) is associated with the 
accumulation of abdominal fat and obesity development as a consequence of consuming food 
rich in saturated fats (14,15). The volunteers with TC genotype were recommended to reduce the 
intake of saturated fatty acids. The beta-2-adrenergic receptor (ADRB2) gene is expressed in 
adipocytes and regulates lipid metabolism. Both polymorphic variants of this gene c.79C>G 
(p.Gin27Glu) (NCBI: rs1042714) and c.46A>G (p.Gly16Arg) (NCBI: rs1042713) may lead to a 
decrease of lipid metabolism and accumulation of fat tissue (16).     
The beta-3-adrenergic receptor (ADRB3) gene is predominantly expressed in the adipose tissue 
and regulates lipid metabolism and thermogenesis. A polymorphism c.190T>C (p.Trp64Arg) 
(NCBI: rs4994) of the ADRB3 gene may lead to impaired lipid metabolism which is related to 
overweight and enlarged waist circumference. Moreover, it has been reported that intensive 
workout decreases BMI in individuals with this genotype (17,18). The association between 
c.190T>C (p.Trp64Arg) polymorphisms and increased BMI is still controversial (19). In 
addition, angiotensin-converting enzyme (ACE) is important in blood pressure control. ACE 
gene insertion is related to a decreased ACE protein activity, therefore, better physical 
endurance. Deletion in this gene, is however, related to an increased ACE protein activity and the 
possibility to perform physical activities that require strength and speed (20-22). A-actinin-3 
(ACTN3) protein is located in fast-contractile muscle fibres that enable explosive force 
production in a short period of time which is ideal for sprint sports (23). Regarding the training 
program of personal genotypes, of 8 volunteers showed a genetic predisposition for an effective 
physiological response to the strength training. According to the genotypes of 10 volunteers, a 
physiological response to the training should be equally effective regardless of the strength- or 
endurance-based training. 
CONCLUSION 
We conclude that optimal nutrition and training plan is crucial for the BMI reduction as observed 
in the overweighed volunteers after the 12-month personalized training and individualized 
nutrition plan. However, the analysed polymorphisms were not significantly associated with the 
obesity in this study. An extended research including genotyping of a larger number of 
participants with the observation of additional anthropometric and physiological parameters 
would provide more reliable data. In general, an individual approach to the obesity problems is 
highly recommended and a genetic analysis of associated polymorphisms can provide valuable 
information for personalized training and diet programs. 
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Table 1. List of polymorphisms of the genes related to diet and exercise 
Gene Polymorphism Protein NCBI 
FABP2 c.163A>G p.Thr55Ala rs1799883 
PPARG c.-2-28078C>G p.Pro12Ala rs1801282 
APOA2 c.-323C>T ////// rs5082 
ADRB279 c.79C>G p.Gin27Glu rs1042714 
ADRB246 c.46A>G p.Gly16Arg rs1042713 
ADRB3 c.190T>C p.Trp64Arg rs4994 
ACTN3 c.1858C>T p.Arg620Ter rs1815739 
ACE 
c.584-109_584-
108ins 
///// rs464994 
MTHFR677 c.665C>T p.Ala222Val rs1801133 
MTHFR1298 c.1409A>C p.Glu470Ala rs1801131 
MCM6 (LCT-
13910) 
c.1917+326C>T ///// rs4988235 
MCM6 (LCT-
22018) 
c.1362+117G>A ///// rs182549 
FUT2 c.461G>A p.Trp154Ter rs601338 
 
 
 
 
 
 
 
Table 2. Volunteers’ personal genotypes 
 PY-
113/15 
PY-
114/15 
PY-
115/15 
PY-
116/15 
PY-
117/15 
PY-
118/15 
PY-
119/15 
PY-
120/15 
PY-
129/15 
GENE GENOT
YPE 
GENOT
YPE 
GENOTY
PE 
GENOTY
PE 
GENOTY
PE 
GENOTY
PE 
GENOT
YPE 
GENOT
YPE 
GENOT
YPE 
Nutrition FABP2 GA GG GG AA GG AA GA GA GG 
PPARG CC CC CC CG CC CC CC CC CG 
APOA2 TT TT TC TC TC TC TT TC TC 
ADRB2 
79  
GG GG GC GC GC CC GC GC CC 
Nutrition 
and 
physical 
activity 
ADRB2 
46 
GG GG GA GA GA AA GA GA GG 
ADRB3 TT TT TT TT TT TT TT TT TT 
Physical 
activity  
ACTN3 CC GG CC CC CT CT CC CC CT 
ACE Ins/Ins Ins/Del Ins/Del Del/Del Ins/Del Del/Del Ins/Del Ins/Ins Del/Del 
Folate 
metabolism 
MTHFR 
677 
CC CT CC CC TT CT CT CT CT 
MTHFR 
1298 
AC AC AA AA AA AA AA AA AC 
 Lactose 
intolerance 
MCM6 
(LCT-
13910) 
CC CT CC CC CT CT CT TT CT 
MCM6 
(LCT-
22018) 
GG GA GG GG GA GA GA AA GA 
Secretor 
status 
FUT2 GG GG GG AA GG GG GG 
 
GA GA 
 PY-
121/15 
PY-
122/15 
PY-
123/15 
PY-
124/15 
PY-
125/15 
PY-
126/15 
PY-
127/15 
PY-
128/15 
PY-
130/15 
FABP2 GA GA GA GA GA AA GG GG GG 
 PPARG CC CC CC CC CC CC CC CC CC 
Nutrition APOA2 TT CC TC TC CC TT TC TC TC 
ADRB2 
79  
GC CC GC GG GC GG CC CC CC 
ADRB2 
46 
GG GA GA GG GA GG GA GA GA 
Nutrition 
and 
physical 
activity 
ADRB3 TT CT TT TT TT TT TT TT TT 
ACTN3 CC CC CT CT CT CT CC CC CT 
Folate 
metabolism 
 
ACE Del/Del Ins/Ins Ins/Del Ins/Del Ins/Del Ins/Del Ins/Del Ins/Del  Ins/Del 
MTHFR 
677 
CC CT CC TT TT CC TT CC CT 
Lactose 
intolerance 
MTHFR 
1298 
AA AC AA AA AA AC AA AC AA 
  
 
 
MCM6 
(LCT-
13910) 
CT CT CC CC CC CT CT CT CT 
 
Secretor 
status 
MCM6 
(LCT-
22018) 
GA GA GA GG GG GA GA GA GA 
FUT2 GA GA GG GA GA GA GA GG AA 
Table 3. BMI values before (BMI-B) and after (BMI-A) the implementation of personalized 
training and nutrition plan; BMI reduction (BMI-diff)  
Sample 
ID 
BMI Sex BMI-P BMI-A BMI-diff 
114 O M 25.1 24.49 0.61 
115 O F 28.4 26.78 1.62 
116 O F 26.56 26.56 0 
117 O M 30.6 29.37 1.23 
118 O M 27.2 27.2 0 
120 O M 28.3 28.3 0 
121 O F 34.78 32.99 1.79 
125 O F 25.31 22.57 2.74 
126 O M 27.1 27.1 0 
128 O F 26.8 25.71 1.09 
130 O M 26 24.93 1.07 
113 N F 20.5 19.84 0.66 
119 N F 23.5 22.52 0.98 
122 N M 22.7 22.7 0 
123 N F 24 22.72 1.28 
124 N M 18.7 18.7 0 
127 N F 20.7 20.7 0 
129 N F 21.7 21.7 0 
 
Table 4. Single-locus case-control test results of the allelic and genotype association between the 
13 observed gene polymorphisms, individual BMI status and gender 
 
BMI status (normal or 
overweight) 
Gender distribution  
Marker Allele 
exact p-
value 
Genotype 
exact p-
value 
Allele exact p-
value 
Genotype 
exact p-
value 
FABP2 1.000 0.101 0.739 1.000 
PPARG 1.000 1.000 0.473 0.461 
APOA2 1.000 1.000 1.000 1.000 
ADRB279 0.753 0.372 1.000 0.188 
ADRB246 0.721 1.000 0.729 0.789 
ADRB3 0.370 0.367 0.453 0.434 
ACTN3 1.000 1.000 0.411 0.351 
ACE 0.493 0.649 0.508 0.657 
MTHFR677 0.493 0.691 0.191 0.107 
MTHFR1298 0.686 0.617 1.000 1.000 
LCT-13910 0.482 0.788 0.162 0.185 
LCT-22018 0.735 0.789 0.168 0.262 
FUT2 0.705 0.788 0.724 1.000 
 
 
Table 5. Single-locus F-test results of the gene polymorphisms and BMI values association 
 
BMI BMI - difference* 
Marker F-statistics P-value F-statistic P-value 
FABP2 0.2394 0.7900 0.0015 0.9986 
PPARG 0.2420 0.6295 1.1623 0.3090 
APOA2 0.2091 0.8137 3.2132 0.0946 
ADRB279 3.5841 0.0534 1.0029 0.4086 
ADRB246 0.1480 0.8637 0.6025 0.5705 
ADRB3 0.5056 0.4873 NaN NaN 
ACTN3 0.1193 0.7343 0.0739 0.79193 
ACE 0.8668 0.4403 1.0376 0.39751 
MTHFR677 0.8585 0.4436 2.6599 0.13013 
MTHFR1298 1.2724 0.2760 0.6140 0.45341 
LCT-13910 0.8285 0.4557 1.0951 0.37985 
LCT-22018 0.6089 0.5569 0.7250 0.51363 
FUT2 0.1316 0.8777 0.2477 0.78637 
* Group of individuals with an increased BMI 
 
 
 
 
  
Figure 1. BMI values before and after the 12-month program (*Individuals who dropped to a 
lower BMI category) 
 
 
 
 
 
 
 
 
